Premium

FDA Approves First-Ever ‘Self-Administered’ Flu ‘Vaccine’ With an Ultra-Sketchy History

AP Photo/Mary Altaffer

This is obviously not medical advice — one is, after all, not allowed to dispense that publicly without the proper credentials, after having been indoctrinated in medical school for several years so, one learns to think and speak right — but it’s my humble opinion that flu vaccines are pharmaceutical trash.

RelatedBill Gates Met With Trump, Pressured Him Not to Investigate Vaccine Safety

The reason they are pharmaceutical trash is not really very complicated: the flu virus (influenza) constantly mutates. This is why it won’t go away and science can’t make it go away, at least not for the foreseeable future.

The pharmaceutical industry, in formulating flu vaccines, tries to identify through what amounts to alchemical divination what the dominant variant will be in any given upcoming flu season.

Putting aside the fact that there are multiple strains in circulation at any given time, by the time the flu vaccine of the year has made it to market and is injected into arms, the virus has already mutated and rendered the inoculation moot.

But don´t take my word for it; consider the warning from Brian Hooker, Ph.D., chief scientific officer for Children’s Health Defense.

Via Children's Health Defense (emphasis added):

Live virus vaccines shed with consequences, especially to pregnant women and infants where this vaccine is contraindicated.

Flu shots in general lead to myriad adverse events, including Guillain-Barré syndrome, and have led to a 4.8-fold increased incidence in non-influenza acute respiratory infections in children under age 5. It is also clear that most years, the flu shot provides minimal protection against the flu. The risks far outweigh any benefits here.

Again, this is very simple logic.

But these products are very profitable, so their purveyors have developed a healthy immunity to logic.

RelatedEXCLUSIVE: FOIA Docs Confirm USDA Lied About Chinese Bird Flu Research Partnership

Via FDA (emphasis added):

Today, the U.S. Food and Drug Administration approved FluMist for self- or caregiver-administration. FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age. FluMist is sprayed into the nose and has been used safely and effectively for many years. It was initially approved by the FDA in 2003 for use in individuals 5 through 49 years of age, and in 2007, the FDA approved the use of FluMist to include children 2 through 5 years of age. It is the first vaccine to prevent influenza, more commonly known as the flu, that does not need to be administered by a health care provider.

“Used safely and effectively for many years.”

What the FDA doesn’t mention is that the exact same vaccine got pulled from the market in 2016 because it actually didn’t work.

Via NBC News, 2018 (emphasis added):

FluMist, the only needle-free flu vaccine on the market, won a lukewarm recommendation from federal vaccine advisers Wednesday.

The nasal spray vaccine has been off the U.S. market for two years because it barely worked against one common strain of flu in kids. The company that makes it, MedImmune, says it has reformulated the vaccine and thinks it will work better next year

There is real worry among flu experts that the poor effectiveness of flu vaccines, especially this past season, may make Americans less willing to get it. The Centers for Disease Control and Prevention recommends that everyone over the age of 6 months get a flu vaccine every year, but fewer than half of all Americans do…

“It’s better than nothing,” said Dr. Grace Lee, a professor of pediatrics at Stanford University School of medicine.

“Better than nothing.” The manufacturer “thinks it will work better next year.”

This is what passes for solid public health guidance these days.

Recommended

Trending on PJ Media Videos

Advertisement
Advertisement